Found 56 matching trials
Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase) PHASE2 Patients presenting to the emergency department with acute ischemic stroke,...
Show More Location
Princess Alexandra Hospital
Learn More & Join Trial
Pulmozyme in Cystic Fibrosis With Sinusitis PHASE3 The hypothesis is that the intranasal use of Pulmozyme will decrease the se...
Show More Location
Penn State Unicersity
Learn More & Join Trial
Pulmozyme for Sjogren's Associated Cough PHASE1 Patients with Sjogren's disease have destruction of the mucus secreting cel...
Show More Location
University of CT Health Center
Learn More & Join Trial
Investigation of the Safety and Feasibility of AAV1/SERCA2a Gene Transfer in Patients With Chronic Heart Failure PHASE2 The aim of the study is to determine the safety and feasibility of giving a...
Show More Location
Papworth Hospital
Learn More & Join Trial
Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19 NA In patients with COVID-19, severe hypoxemic respiratory failure (SRF) leadi...
Show More Location
University Hospital of Alexandroupolis
Learn More & Join Trial
Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of AIR DNaseā¢in Patients With Cystic Fibrosis Previously Treated With PulmozymeĀ® PHASE2 This study evaluates the Safety,Tolerability, Pharmacokinetics and Explorat...
Show More Learn More & Join Trial
Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94 PHASE1 Study 1304 is a Phase I dose escalation study conducted in adults with pers...
Show More Location
UCLA Division of Rheumatology
Learn More & Join Trial
Empyema Treated With tPA & DNAse PHASE3 The objective of this study is to scientifically evaluate a new substrate f...
Show More Location
Children's Mercy Hospital
Learn More & Join Trial
Thermosensitive Gel Nasal Spray With Stem Cell Exosomes, Mupirocin, and DNase I for Chronic Sinusitis EARLY_PHASE1 This study tests a new nasal spray for adults (18-65 years) with chronic rh...
Show More Location
Multiple Locations
Learn More & Join Trial
Nebulised Dornase Alfa for Treatment of COVID-19 (Coronavirus Disease 2019) PHASE2 An open-label, randomised, Best-Available-Care (BAC) and historic-controlle...
Show More Location
University College London Hospital
Learn More & Join Trial